Skip to main content
. Author manuscript; available in PMC: 2013 Sep 15.
Published in final edited form as: Cancer. 2012 Jan 26;118(18):4502–4511. doi: 10.1002/cncr.27409

Table 1.

Characteristics of patients

Molecular Cohort

Characteristic ALK+ EGFR+ KRAS+ Triple
Negative
Total
Total 41 (20) 39 (19) 49 (23) 80 (38) 209
Histology
   Adenocarcinoma 38 (93) 37 (95) 47 (96) 78 (98) 200 (96)
   Large cell 1 (2) 0 2 (4) 0 5 (2)
   NOS 2 (5) 2 (5) 0 2 (3) 6 (3)
Staging
   Stage IV at diagnosis 35 (85) 28 (72) 39 (80) 63 (79) 165 (79)
   Recurrent disease 6 (15) 11 (28) 10 (20) 17 (21) 44 (21)
Smoking history
   Never (<100 cigarettes) 31 (76) 22 (56) 6* (12) 25 (31) 84 (40)
   Light (≤10 py) 5 (12) 5 (13) 1 (2) 9 (11) 20 (10)
   Current/former 5 (12) 12 (31) 42 (86) 46 (58) 105 (50)
     Mean Pack Years 22.6 43.9 46.2 39.8 42
Sex
   Male 21 (51) 10 (26) 14 (29) 38 (48) 83 (40)
   Female 20 (49) 29 (74) 35 (71) 42 (52) 126 (60)
Median age, years (range) 51 (21–78) 62 (45–78) 59.5 (32–82) 62 (41–82) 59 (21–82)
*

includes one pipe smoker,

age at diagnosis of metastatic disease